Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands
US6331629A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2000 |
| Grant date | Dec 18, 2001 |
| Priority date | — |
| Expiry date | Mar 9, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds of the formula: ##STR1## or pharmaceutically acceptable addition salts thereof, wherein: PA1 X, Y and Z are the same or different and represent optionally substituted carbon or nitrogen; PA1 R.sub.1 and R.sub.2 independently represent organic or inorganic substituents; PA1 R.sub.3 and R.sub.4 are variables independently representing inorganic or organic substituents; PA1 A represents C.sub.1 -C.sub.4 alkylene; and PA1 R.sub.5, R.sub.6, and R.sub.7 independently represent hydrogen or C.sub.1 -C.sub.6 alkyl, PA2 which compounds bind selectively with high affinity to the dopamine D.sub.4 receptor subtype and are therefore of use in treatment of various neuropsychological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.